RxDoctor Payments Data

Hasan Badday, MD

Interventional Pain Medicine · Irvine, CANPI 1225293095

Payments from drug & device makers

$6,150in general payments, 2019–2025

Across 189 payments — averaging $32.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Relievant Medsystems, Inc.$988
  • Stryker$864
  • Nevro Corp.$778
  • Forte Bio-pharma LLC$500
  • Collegium Pharmaceutical, Inc.$176
  • plus $2K from 30 others

What the payments were for

  • Travel & lodging$1,47824%
  • Food & beverage$4,67376%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,150 in reported general payments places this provider in the 65th percentile of 188 interventional pain medicine providers in California.

See all interventional pain medicine providers in California

Medicare billing

Part B allowed, 2024
$175,905
Medicare patients
166
Services billed
1,594

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl15$8,318
Diclofenac Sodium46$7,142
Buprenorphine15$4,223
Chlorzoxazone16$3,516
Cyclobenzaprine Hcl194$2,406
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen79$2,118
Fentanyl18$2,041
Ibuprofen239$1,983
Celecoxib60$1,371
Oxycodone Hcl43$1,347
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen32$943
Morphine Sulfate ErMorphine Sulfate28$711
Gabapentin33$393
Pregabalin15$314
Methylprednisolone13$77

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Irvine

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →